Treatment Strategy and Daily Management of NISCS
At a Glance
NISCS has no single curative treatment; care is individualized and focuses on protecting the infant’s skin, monitoring bile flow and liver function, replacing vitamins, supporting calories and growth, relieving itching, and referring early for transplant evaluation if liver disease progresses.
Because Neonatal Ichthyosis-Sclerosing Cholangitis Syndrome (NISCS) is exceptionally rare, there is no single curative treatment. Instead, your child’s medical team will focus on symptom-directed management—treating each part of the condition as it appears and adjusting care as your child grows [1][2]. This typically involves a “multidisciplinary” team of specialists, including dermatologists, liver specialists (hepatologists), and dietitians, all working together to support your child’s health [1]. Do not start, stop, or adjust any medications, supplements, or special diets without explicit instructions from your child’s clinical team.
Daily Care for the Skin
The main goal of skin care in NISCS is to support the skin’s weakened barrier and keep it as hydrated as possible. In infants, severe generalized ichthyosis presents critical safety risks, including difficulty regulating body temperature, severe dehydration, and an increased risk of serious infections.
- Emollients and Moisturizers: The foundation of care is the frequent, generous application of emollients—thick, bland creams or ointments that seal in moisture [3]. These should be applied several times a day, especially after bathing while the skin is still damp.
- Monitoring for Infection: Because the skin’s “seal” is broken, it is easier for bacteria to get in. You should watch for signs of a skin infection, such as increasing redness, oozing, pain, or fever [4]. If an infant develops a fever, it requires urgent assessment. If you notice these signs, contact your team promptly.
- Specialist Treatments (Use with Caution): In some cases, doctors may recommend keratolytics—special creams designed to help thin and soften thick scales—but these must be used with extreme caution. Do not use over-the-counter acids (such as salicylic acid) on infants, especially over large areas. They should only be used if explicitly prescribed by a pediatric dermatologist [5].
Managing Liver Health
Liver management focuses on monitoring bile flow and replacing the nutrients that the body might not be absorbing correctly.
- Ursodeoxycholic Acid (UDCA): This is a medication sometimes used to help improve bile flow and lower liver enzyme levels [2][6]. In some small case reports of children with NISCS, UDCA has been associated with improved liver tests, though its long-term effects on bile-duct scarring are still being studied [2]. Normal enzymes do not prove that underlying scarring has stopped. Only your hepatologist can decide if this is appropriate.
- Fat-Soluble Vitamin Supplementation: When bile doesn’t flow correctly, the body has trouble absorbing “fat-soluble” vitamins—specifically Vitamins A, D, E, and K [7][8]. These vitamins are essential for vision, bone health, and blood clotting. Your child will likely need individualized doses of these vitamins, which their doctor will monitor through regular blood tests (Vitamin K is often assessed through clotting tests like PT/INR). Do not supplement these on your own, as excessive Vitamins A and D can be highly toxic [8][9].
- Managing Itching: Some children experience cholestatic pruritus, or intense itching caused by bile backup. Doctors may use medications like cholestyramine to help provide relief, but this requires supervision as it can interfere with the absorption of other medicines and vitamins [10].
Nutrition and Growth
Children with chronic liver and skin issues often have much higher energy needs than other children. This is because their bodies are working harder to maintain a skin barrier and manage liver inflammation [11][12].
- Extra Calories: A pediatric dietitian may recommend a high-calorie diet to support healthy growth and weight gain [11].
- MCT Oil: Doctors and dietitians may suggest using Medium-Chain Triglyceride (MCT) oil, a type of fat that the body can absorb more easily even when bile flow is low [13]. This must be carefully planned by the medical team to provide the extra energy your child needs for growth [14].
Early Referral for Transplant Evaluation
While many children with NISCS have liver issues that remain stable or even improve, a small number will develop advanced liver disease [1].
In the 37 cases reported worldwide in a historical review, 5 children eventually required a liver transplant [1]. It is crucial to understand that referral to a transplant center does not mean a transplant is automatic or inevitable. Pediatric hepatologists often refer patients early for specialist evaluation based on the child’s overall clinical course, synthetic dysfunction (e.g., poor clotting or low albumin), recurrent complications, or progressive disease that cannot be managed with medication [15][16]. Early referral allows the transplant center to safely assess the child before emergency, end-stage liver failure occurs [15].
Common questions in this guide
Is there a cure for neonatal ichthyosis-sclerosing cholangitis syndrome?
How should I care for my baby’s skin with NISCS?
Why does my child with NISCS need vitamins A, D, E, and K?
What treatments may help NISCS-related liver problems and itching?
How can nutrition support growth in a child with NISCS?
When should a child with NISCS be referred for transplant evaluation?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Liver treatment options
Is ursodeoxycholic acid (UDCA) an option for my child's liver health?
Vitamin monitoring
How will my child's fat-soluble vitamin levels be monitored with regular blood tests?
Nutrition and growth
Could you explain how calorie and MCT oil plans are set for my child's growth?
Get notified when new evidence is published on Neonatal ichthyosis-sclerosing cholangitis syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Neonatal ichthyosis-sclerosing cholangitis syndrome caused by a novel CLDN1 mutation: a case report and literature review.
Ghosh U, Agrawal A, Srinivasan VM, et al.
Clinical and experimental pediatrics 2025; (68(11)):858-867 doi:10.3345/cep.2025.00906.
PMID: 41035246 - 2
[NISCH syndrome, a rare cause of neonatal cholestasis: A case report].
Szepetowski S, Lacoste C, Mallet S, et al.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2017; (24(12)):1228-1234 doi:10.1016/j.arcped.2017.09.016.
PMID: 29146216 - 3
Dermatology Part 2: Ichthyoses and Psoriasis.
Sticherling M
Handbook of experimental pharmacology 2020; (261()):153-175 doi:10.1007/164_2019_345.
PMID: 32006258 - 4
Infant skin care: updates and recommendations.
Johnson E, Hunt R
Current opinion in pediatrics 2019; (31(4)):476-481 doi:10.1097/MOP.0000000000000791.
PMID: 31188166 - 5
Erythrokeratodermia variabilis et progressiva.
Ishida-Yamamoto A
The Journal of dermatology 2016; (43(3)):280-5 doi:10.1111/1346-8138.13220.
PMID: 26945536 - 6
Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group.
van Rheenen PF, Kolho KL, Russell RK, et al.
Journal of pediatric gastroenterology and nutrition 2025; (80(2)):374-393 doi:10.1002/jpn3.12378.
PMID: 39741383 - 7
Fat-Soluble Vitamins Deficiency in Pediatric Cholestasis: A Scoping Review.
Degrassi I, Leonardi I, Di Profio E, et al.
Nutrients 2023; (15(11)) doi:10.3390/nu15112491.
PMID: 37299454 - 8
Fat soluble vitamins deficiency in pediatric chronic liver disease: The impact of liver transplantation.
Veraldi S, Pietrobattista A, Liccardo D, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2020; (52(3)):308-313 doi:10.1016/j.dld.2019.10.005.
PMID: 31734113 - 9
ACG Clinical Guideline: Primary Sclerosing Cholangitis.
Lindor KD, Kowdley KV, Harrison ME,
The American journal of gastroenterology 2015; (110(5)):646-59; quiz 660 doi:10.1038/ajg.2015.112.
PMID: 25869391 - 10
Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE, Namer B, Bolier R, et al.
Digestive diseases (Basel, Switzerland) 2015; (33 Suppl 2()):164-75 doi:10.1159/000440829.
PMID: 26641452 - 11
Malnutrition in Pediatric Chronic Cholestatic Disease: An Up-to-Date Overview.
Tessitore M, Sorrentino E, Schiano Di Cola G, et al.
Nutrients 2021; (13(8)) doi:10.3390/nu13082785.
PMID: 34444944 - 12
Sarcopenia and nutritional impact in pediatric patients with chronic liver disease: Clinical and management strategies.
Kehar M, Ayala-German AG, Pandey A, et al.
Journal of pediatric gastroenterology and nutrition 2026; (82(6)):1329-1340 doi:10.1002/jpn3.70367.
PMID: 41925071 - 13
Medium-chain triglycerides and the impact on fat absorption, growth, nutritional status and clinical outcomes in children with cholestatic liver disease: A scoping review.
Mancell S, Manwani K, Dhawan A, Whelan K
Clinical nutrition (Edinburgh, Scotland) 2023; (42(11)):2159-2172 doi:10.1016/j.clnu.2023.09.010.
PMID: 37776587 - 14
Nutrition support of children with chronic liver disease: A rapid review and consensus statements from Australasian society of parenteral and enteral nutrition (AuSPEN) Paediatric liver group.
Burgess D, Collins T, Landorf E, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2026; (58(7)):862-870 doi:10.1016/j.dld.2026.05.006.
PMID: 42225462 - 15
Update in the Care and Management of Patients with Primary Sclerosing Cholangitis.
Sedki M, Levy C
Current gastroenterology reports 2018; (20(7)):29 doi:10.1007/s11894-018-0635-8.
PMID: 29886518 - 16
Liver Transplantation for Cholestatic Liver Diseases in Adults.
Khungar V, Goldberg DS
Clinics in liver disease 2016; (20(1)):191-203.
PMID: 26593299
This page is for informational purposes only and does not constitute medical advice about your child’s NISCS. Follow the individualized guidance of your child’s dermatologist, hepatologist, dietitian, and other clinical specialists before changing medicines, supplements, skin care, or diet.